RAPIDOME

Owner

Goods & Services

Drug discovery services; providing information on the testing, inspection and research of medical products; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; development of pharmaceutical preparations and medicines; consultancy in the field of testing, inspection, research of medical products; scientific research conducted using databases; development of computer software for big data processing; research and development services in the field of chemistry; provision of scientific information relating to chemicals; chemical analysis; research and development of vaccines and medicines; research and development of pharmaceutical preparations for treating malignant tumours; computer programming in the medical field; research and development services in the field of microorganisms and cells; biotechnology research; scientific research; computer software development; drug discovery services by computer modeling; research and development of computer software platforms in the field of artificial intelligence; software as a service [SaaS] relating to artificial intelligence based deep learning software for visual and data analysis in the medical and biotechnological field; software as a service [SaaS] relating to software for data collection, data analysis, data storing and data mining in the field of healthcare and biotechnology; software development for artificial intelligence service; providing PaaS (platform as a service) in the field of pharmaceuticals; computer software development for promoting research in science, medicine, pharmaceutical, biology, biotechnology, biological informatics, clinical development and statistics fields; computer software development for data analysis in medical and biotechnology fields using algorithms for deep learning; computer software development in the field of new drug discovery and new drug development.